News from ventana medical systems, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 27, 2015, 08:30 ET
Halozyme Therapeutics, Inc. Logo.

Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment

Halozyme Therapeutics, Inc. (NASDAQ: HALO) and Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today a global...

Apr 14, 2015, 10:00 ET
FGFRs (Fibroblast growth factor receptors) are receptors that bind growth factors responsible for cell proliferation, growth, structure, movement and shape. In some tumor cells, blocking FGFR activity may be advantageous in stopping tumor growth.

Ventana Medical Systems, Inc. and Astellas Pharma join forces to leverage novel companion diagnostic tests for targeted cancer treatments

 Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced it has entered into master collaboration...

Mar 03, 2015, 09:00 ET
Dr. Thomas Grogan, Ventana Founder and Chief Scientific Advisor

Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium

 The eleventh annual Tucson Symposium will be held March 17-18, where more than 450 of the world's top research scientists, academics,...

Jan 21, 2015, 09:00 ET
Positive case of lung tissue stained for ALK with VENTANA ALK (D5F3) CDx Assay

Ventana seeks FDA premarket approval for ALK IHC companion diagnostic to benefit lung cancer patients

 Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced its FDA submission for premarket approval (PMA) of the...

Oct 28, 2014, 11:00 ET

Ventana announces collaboration to develop companion diagnostics for ImmunoGen's targeted anticancer agents

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced it has entered into an agreement with...

Aug 20, 2014, 10:00 ET
VENTANA System for Primary Diagnosis. (PRNewsFoto/Ventana Medical Systems, Inc.)

Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis

 Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that its VENTANA System for Primary...

Aug 05, 2014, 10:00 ET
Exploratory testing in the Ventana Medical Systems, Inc. CAP/CLIA laboratory at Quintiles China (PRNewsFoto/Ventana Medical Systems, Inc.)

Ventana paves the way for companion diagnostic early phase clinical trials in China to advance patient care

 Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announces a new agreement with Quintiles, Inc. to...

Jul 10, 2014, 10:00 ET

Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment

 Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced it has entered into an agreement with...

Jun 04, 2014, 10:00 ET
PD-L1 (SP263) Positive. Lung tissue at 20x magnification, stained on a BenchMark ULTRA instrument. (PRNewsFoto/Ventana Medical Systems, Inc.)

Ventana Medical Systems, Inc. and MedImmune collaborate to develop a custom PD-L1 Assay for immunotherapy clinical trials

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group and MedImmune, the global biologics research and development arm of...

May 21, 2014, 10:00 ET
FGFR2 (fibroblast growth factor receptor 2) Gastric tissue at 20x stained on a VENTANA BenchMark XT (PRNewsFoto/Ventana Medical Systems, Inc.)

Ventana Companion Diagnostics CAP/CLIA lab launches new Robust Prototype Assays

 Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the launch of three new companion...

May 19, 2014, 10:00 ET

Ventana launches new software platform for enhanced pathology education

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announces the release of VENTANA Vector software, a new platform for...

Apr 03, 2014, 10:00 ET

Ventana signs companion diagnostic agreement with international biotech for antibody drug conjugate program

 Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has entered into an agreement...

Mar 27, 2014, 10:00 ET

Ventana supports World Health Organization's global classification of haematopoietic and lymphoid cancers

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group has made an educational grant to support the World Health Organization (WHO)...

Mar 11, 2014, 09:00 ET

Ventana and Bayer Extend Collaboration

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has entered into a multi-year agreement with Bayer...

Mar 05, 2014, 11:00 ET

International Panel of Pathology Leaders Develop Principles for Patient Safety

An international panel of leaders in the pathology community today announced its support of four principles designed to drive positive change and...

Feb 25, 2014, 15:30 ET

Ventana Medical Systems, Inc., Convenes International Patient Safety Advisory Board To Advance Standard Of Care And Reduce Risk Of Misdiagnosis

 Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it will convene a Tissue Diagnostics Patient Safety...

Feb 13, 2014, 15:00 ET

Tucson To Host Globally Recognized Cancer Research Conference Feb. 25 And 26

The world's top scientific minds will convene at Tucson's Hilton El Conquistador Resort February 25 and 26 to collaborate and share leading-edge...

Dec 13, 2013, 08:00 ET
Breast carcinoma HER2 (4B5) positive, Score: 3  Magnification: 40X.  (PRNewsFoto/Ventana Medical Systems, Inc.)

Ventana announces HER2 companion diagnostic to identify breast cancer patients for Roche's latest targeted medicines, Perjeta and Kadcyla

 Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announces the VENTANA HER2/neu (4B5) Rabbit Monoclonal Primary...

Dec 05, 2013, 08:00 ET
VENTANA Companion Algorithm ER (SP1)image analysis algorithm.  (PRNewsFoto/Ventana Medical Systems, Inc.)

Ventana receives FDA clearance for Estrogen Receptor (ER) Image Analysis and Digital Read Application for breast cancer

 Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration...

Nov 26, 2013, 06:00 ET

Ventana presents CareGiver remote support at 2013 DreamForce

 At this year's DreamForce conference in San Francisco, California, Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group,...